Metraipolis › archive › dc_ebb0bc1ba836
Engagement of outpatient providers in a deprescribing trial for hospitalized older patients transitioning to post-acute care facilities — Europe PMC PMID:41550262
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41550262
- DOI
- 10.1080/28355245.2025.2587314
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T08:50:19.944Z
- SHA-256 of the archived text
74e25ac7ec7f5d5384f1e3026941e24aed948b5fd01934c6c42e1834e7f1ebab- Stable URL of this page
https://metraipolis.com/documento/dc_ebb0bc1ba836
How to cite
Engagement of outpatient providers in a deprescribing trial for hospitalized older patients transitioning to post-acute care facilities — Europe PMC PMID:41550262 — Europe PMC (en), https://europepmc.org/article/MED/41550262 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ebb0bc1ba836 (Metraipolis archive dc_ebb0bc1ba836, sha256 74e25ac7ec7f5d5384f1e3026941e24aed948b5fd01934c6c42e1834e7f1ebab)
BibTeX
@misc{dcebb0bc1ba836,
title = {Engagement of outpatient providers in a deprescribing trial for hospitalized older patients transitioning to post-acute care facilities — Europe PMC PMID:41550262},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41550262},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ebb0bc1ba836; sha256 74e25ac7ec7f5d5384f1e3026941e24aed948b5fd01934c6c42e1834e7f1ebab},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41550262. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Deprescribing to reduce polypharmacy often involves conversations between patients and their providers. Prior studies have surveyed healthcare providers' willingness to deprescribe medications for hypothetical patients and defined barriers and enablers to deprescribing from provider perspectives. Few studies, however, have examined provider barriers and enablers based on their response to actual deprescribing recommendations for patients during care transitions. Aims: To assess providers' response to deprescribing recommendations for patients enrolled in the Shed-MEDS clinical trial. Methods: This was a mixed methods study within the Shed-MEDS clinical trial, which included older patients with polypharmacy transitioning from the hospital to post-acute care (PAC) for short-term rehabilitation to home. During hospitalization, a study clinician reviewed all medications taken by each patient at home and in hospital, including prescribed and over-the-counter medications. The study clinician then discussed deprescribing recommendations for medications with the patient. If the patient agreed, the study clinician contacted the outpatient prescribing provider to discuss deprescribing recommendations and assess provider agreement. Providers' responses were categorized into barriers and enablers using a published framework: awareness, inertia, self-efficacy, feasibility, and/or tacit (no clear reason given). Responses were analyzed using descriptive statistics. Results: Of 186 patients randomized to the intervention, 177 completed the deprescribing discussion with the study clinician. The study clinician was successful in contacting at least one outpatient provider for 101 patients. Among 101 patients, 983 outpatient medications were recommended for deprescribing. Patients agreed to deprescribe most of these medications (72%). The study clinician was able to discuss deprescribing with outpatient providers for 315 medications, of which they agreed to deprescribe 273 (87%). Vitamins and supplements were discussed most often. Ultimately, 242 (89%) medications that providers agreed to were successfully deprescribed. The most common provider enablers to deprescribing were categorized as tacit (37%), self-efficacy (30%), and inertia (27%). However, inertia (60%) and self-efficacy (42%) also were common provider barriers. Conclusions: Outpatient providers agreed with most deprescribing recommendations shared by a study clinician following patient agreement. The most common barrier to deprescribing among outpatient providers was their preference not to change medicines (inertia) and/or not feeling confident in their ability to make these changes (self-efficacy). Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Health literacy and communication open, 2025 (prima pubblicazione 2025-11-17). Identificativi: PMID 41550262 · PMCID PMC12811018 · DOI 10.1080/28355245.2025.2587314. Parole chiave degli autori: Outpatient; Polypharmacy; Barriers; Deprescribing; Prescribers. Pagina: https://europepmc.org/article/MED/41550262 — https://doi.org/10.1080/28355245.2025.2587314. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T08:20:26.615Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.